Product Images Losartan Potassium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Losartan Potassium NDC 63187-296 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

63187-296-90 - losartan50mg30s

63187-296-90 - losartan50mg30s

Losartan Potassium 50mg tablets are sold in a bottle of 30. The tablets are white to off-white, film-coated, and oval-shaped. The manufacturer is Hetero Labs Limited, with a product ID of RL029630. The tablets contain 50 mg of Losartan Potassium USP. They should be stored at a temperature between 20°C-25°C, and packaged in a bottle with the lot number of 00000. The tablets are prescription-only medication that should be kept out of children's reach. The scan provided is for Relabeled By Proficient Rx LP.*

losartanaddress1 - losartanaddress1

losartanaddress1 - losartanaddress1

losartanaddress2 - losartanaddress2

losartanaddress2 - losartanaddress2

losartanfigure1 - losartanfigure1

losartanfigure1 - losartanfigure1

losartanfigure2 - losartanfigure2

losartanfigure2 - losartanfigure2

This is a statistical or clinical study with a graph that shows the percentage of patients experiencing first-line or fatal stroke over time (measured in months). The study reports an adjusted risk reduction of 26% with a p-value of 0.001. No other information is available.*

losartanfigure3 - losartanfigure3

losartanfigure3 - losartanfigure3

This appears to be a table or figure of some sort, showing the number of events related to a composite primary endpoint broken down by demographic subgroups and different treatments. Without more context, it is not clear what the primary endpoint or treatments are for.*

losartanfigure4 - losartanfigure4

losartanfigure4 - losartanfigure4

The text is describing the percentage of patents with an event related to risk reduction, which is 18.1%. The unit of time for this percentage is not specified, but it is associated with the duration of several months. The text provided does not give enough information to determine what the unit of months refers to exactly.*

losartanstructure - losartanstructure

losartanstructure - losartanstructure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.